Loading clinical trials...
Loading clinical trials...
Peri-operative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis: a Prospective Randomized Clinical Trial
Conditions
Interventions
Peri-operative chemotherapy
postoperative chemotherapy
Locations
1
China
Jiangsu province hospital
Nanjing, Jiangsu, China
Start Date
October 1, 2016
Primary Completion Date
October 1, 2023
Completion Date
October 1, 2023
Last Updated
September 23, 2016
NCT04704661
NCT04674267
NCT04668872
NCT05672108
NCT07321106
NCT06051695
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions